Overview

  • Dr Satish Kumar. A is a clinical Hematologist, Haemato-oncologist and BMT physician and has experience of more than 14 years in the field

  • He is the Hemato-oncologist in Yeshwanthpur Bangalore and Bone Marrow Transplant Physician in Yeshwanthpur Bangalorehas completed DM from prestigious Seth G S Medical college (KEM Hospital) and later pursued Fellowship in Leukemia and Bone Marrow Transplant from Vancouver, Canada
  • He specializes in management of benign and malignant disorders of blood and bone marrow including Stem cell transplantation
  • His expertise includes management of various anaemias, platelet disorders, bleeding and clotting disorders, and blood cancers including Leukaemia, Lymphoma and Myeloma
  • He has expertise to manage blood disorders including cancers in both adults and children

  • Field of Expertise

  • Clinical Hematology
  • Hemato - Oncology
  • Stem Cell Transplant
  • Fellowship & Membership

  • Fellowship in Leukemia and BMT.
  • Languages Spoken

  • English
  • Kannada
  • Hindi
  • Telugu
  • Awards & Achievements

  • Topper in DM Hematology exam at Mumbai university in 2007.
  • Talks & Publications

  • A Rare case of familial multiple subcutaneous lipomatosis with novel PALB2 mutation and increased prediction to cancer: Hematol Oncol Stem Cell Ther (2016) 9, 154-156.
  • Heamophagocytic Lymphohistiocytosis (HLH): Case Series in Tertiary Referral Hospital Over Three Years: Journal Of The Association Of Physicians Of India -Nov 2013;Vol.61.
  • Comparison of Diagnostic Yield of FISH Panel Against Conventional Cytogenetic Studies for Hematological Malignancies: A South Indian Referral Laboratory Analysis Of 201 Cases: Asian Pac J Cancer Prev, 18(12), 3457-3464.
  • Halving Time of BCR-ABLI in Chronic Myeloid Leukemia: Is it Better Than Day-90 Value; A Multi-center Study From South India: J of Int Myeloma & Society of Hemotologic Oncology-May 2020
  • Does Interim PET Scan After 2 Cycles Of ABVD Predict Outcome in Hodgkin Lymphoma? RWE: J Global Oncology,Sep2020.
  • Ring Chromosome 8 as a sole abnormality: An adverse prognostic indicator in Acute Myeloid Leukemia?: Atlas Genet Cytogenet Oncol Heamatol.2018;22(1).
  • Dr Satish Kumar on Five incredible facts about chemotherapy I Mirchi Plus Click Here

    Fellowship & Membership

  • Fellowship in Leukemia and BMT.
  • Overview

  • Dr Satish Kumar. A is a clinical Hematologist, Haemato-oncologist and BMT physician and has experience of more than 14 years in the field

  • He is the Hemato-oncologist in Yeshwanthpur Bangalore and Bone Marrow Transplant Physician in Yeshwanthpur Bangalorehas completed DM from prestigious Seth G S Medical college (KEM Hospital) and later pursued Fellowship in Leukemia and Bone Marrow Transplant from Vancouver, Canada
  • He specializes in management of benign and malignant disorders of blood and bone marrow including Stem cell transplantation
  • His expertise includes management of various anaemias, platelet disorders, bleeding and clotting disorders, and blood cancers including Leukaemia, Lymphoma and Myeloma
  • He has expertise to manage blood disorders including cancers in both adults and children

  • Field of Expertise

  • Clinical Hematology
  • Hemato - Oncology
  • Stem Cell Transplant
  • Languages Spoken

  • English
  • Kannada
  • Hindi
  • Telugu
  • Awards & Achievements

  • Topper in DM Hematology exam at Mumbai university in 2007.
  • Talks & Publications

  • A Rare case of familial multiple subcutaneous lipomatosis with novel PALB2 mutation and increased prediction to cancer: Hematol Oncol Stem Cell Ther (2016) 9, 154-156.
  • Heamophagocytic Lymphohistiocytosis (HLH): Case Series in Tertiary Referral Hospital Over Three Years: Journal Of The Association Of Physicians Of India -Nov 2013;Vol.61.
  • Comparison of Diagnostic Yield of FISH Panel Against Conventional Cytogenetic Studies for Hematological Malignancies: A South Indian Referral Laboratory Analysis Of 201 Cases: Asian Pac J Cancer Prev, 18(12), 3457-3464.
  • Halving Time of BCR-ABLI in Chronic Myeloid Leukemia: Is it Better Than Day-90 Value; A Multi-center Study From South India: J of Int Myeloma & Society of Hemotologic Oncology-May 2020
  • Does Interim PET Scan After 2 Cycles Of ABVD Predict Outcome in Hodgkin Lymphoma? RWE: J Global Oncology,Sep2020.
  • Ring Chromosome 8 as a sole abnormality: An adverse prognostic indicator in Acute Myeloid Leukemia?: Atlas Genet Cytogenet Oncol Heamatol.2018;22(1).
  • Dr Satish Kumar on Five incredible facts about chemotherapy I Mirchi Plus Click Here

    Languages Spoken

  • English
  • Kannada
  • Hindi
  • Telugu
  • Overview

  • Dr Satish Kumar. A is a clinical Hematologist, Haemato-oncologist and BMT physician and has experience of more than 14 years in the field

  • He is the Hemato-oncologist in Yeshwanthpur Bangalore and Bone Marrow Transplant Physician in Yeshwanthpur Bangalorehas completed DM from prestigious Seth G S Medical college (KEM Hospital) and later pursued Fellowship in Leukemia and Bone Marrow Transplant from Vancouver, Canada
  • He specializes in management of benign and malignant disorders of blood and bone marrow including Stem cell transplantation
  • His expertise includes management of various anaemias, platelet disorders, bleeding and clotting disorders, and blood cancers including Leukaemia, Lymphoma and Myeloma
  • He has expertise to manage blood disorders including cancers in both adults and children

  • Fellowship & Membership

  • Fellowship in Leukemia and BMT.
  • Field of Expertise

  • Clinical Hematology
  • Hemato - Oncology
  • Stem Cell Transplant
  • Awards & Achievements

  • Topper in DM Hematology exam at Mumbai university in 2007.
  • Talks & Publications

  • A Rare case of familial multiple subcutaneous lipomatosis with novel PALB2 mutation and increased prediction to cancer: Hematol Oncol Stem Cell Ther (2016) 9, 154-156.
  • Heamophagocytic Lymphohistiocytosis (HLH): Case Series in Tertiary Referral Hospital Over Three Years: Journal Of The Association Of Physicians Of India -Nov 2013;Vol.61.
  • Comparison of Diagnostic Yield of FISH Panel Against Conventional Cytogenetic Studies for Hematological Malignancies: A South Indian Referral Laboratory Analysis Of 201 Cases: Asian Pac J Cancer Prev, 18(12), 3457-3464.
  • Halving Time of BCR-ABLI in Chronic Myeloid Leukemia: Is it Better Than Day-90 Value; A Multi-center Study From South India: J of Int Myeloma & Society of Hemotologic Oncology-May 2020
  • Does Interim PET Scan After 2 Cycles Of ABVD Predict Outcome in Hodgkin Lymphoma? RWE: J Global Oncology,Sep2020.
  • Ring Chromosome 8 as a sole abnormality: An adverse prognostic indicator in Acute Myeloid Leukemia?: Atlas Genet Cytogenet Oncol Heamatol.2018;22(1).
  • Dr Satish Kumar on Five incredible facts about chemotherapy I Mirchi Plus Click Here

    Field of Expertise

  • Clinical Hematology
  • Hemato - Oncology
  • Stem Cell Transplant
  • Fellowship & Membership

  • Fellowship in Leukemia and BMT.
  • Languages Spoken

  • English
  • Kannada
  • Hindi
  • Telugu
  • Awards & Achievements

  • Topper in DM Hematology exam at Mumbai university in 2007.
  • Talks & Publications

  • A Rare case of familial multiple subcutaneous lipomatosis with novel PALB2 mutation and increased prediction to cancer: Hematol Oncol Stem Cell Ther (2016) 9, 154-156.
  • Heamophagocytic Lymphohistiocytosis (HLH): Case Series in Tertiary Referral Hospital Over Three Years: Journal Of The Association Of Physicians Of India -Nov 2013;Vol.61.
  • Comparison of Diagnostic Yield of FISH Panel Against Conventional Cytogenetic Studies for Hematological Malignancies: A South Indian Referral Laboratory Analysis Of 201 Cases: Asian Pac J Cancer Prev, 18(12), 3457-3464.
  • Halving Time of BCR-ABLI in Chronic Myeloid Leukemia: Is it Better Than Day-90 Value; A Multi-center Study From South India: J of Int Myeloma & Society of Hemotologic Oncology-May 2020
  • Does Interim PET Scan After 2 Cycles Of ABVD Predict Outcome in Hodgkin Lymphoma? RWE: J Global Oncology,Sep2020.
  • Ring Chromosome 8 as a sole abnormality: An adverse prognostic indicator in Acute Myeloid Leukemia?: Atlas Genet Cytogenet Oncol Heamatol.2018;22(1).
  • Dr Satish Kumar on Five incredible facts about chemotherapy I Mirchi Plus Click Here
  • Overview

  • Dr Satish Kumar. A is a clinical Hematologist, Haemato-oncologist and BMT physician and has experience of more than 14 years in the field

  • He is the Hemato-oncologist in Yeshwanthpur Bangalore and Bone Marrow Transplant Physician in Yeshwanthpur Bangalorehas completed DM from prestigious Seth G S Medical college (KEM Hospital) and later pursued Fellowship in Leukemia and Bone Marrow Transplant from Vancouver, Canada
  • He specializes in management of benign and malignant disorders of blood and bone marrow including Stem cell transplantation
  • His expertise includes management of various anaemias, platelet disorders, bleeding and clotting disorders, and blood cancers including Leukaemia, Lymphoma and Myeloma
  • He has expertise to manage blood disorders including cancers in both adults and children

    Awards & Achievements

  • Topper in DM Hematology exam at Mumbai university in 2007.
  • Fellowship & Membership

  • Fellowship in Leukemia and BMT.
  • Field of Expertise

  • Clinical Hematology
  • Hemato - Oncology
  • Stem Cell Transplant
  • Languages Spoken

  • English
  • Kannada
  • Hindi
  • Telugu
  • Talks & Publications

  • A Rare case of familial multiple subcutaneous lipomatosis with novel PALB2 mutation and increased prediction to cancer: Hematol Oncol Stem Cell Ther (2016) 9, 154-156.
  • Heamophagocytic Lymphohistiocytosis (HLH): Case Series in Tertiary Referral Hospital Over Three Years: Journal Of The Association Of Physicians Of India -Nov 2013;Vol.61.
  • Comparison of Diagnostic Yield of FISH Panel Against Conventional Cytogenetic Studies for Hematological Malignancies: A South Indian Referral Laboratory Analysis Of 201 Cases: Asian Pac J Cancer Prev, 18(12), 3457-3464.
  • Halving Time of BCR-ABLI in Chronic Myeloid Leukemia: Is it Better Than Day-90 Value; A Multi-center Study From South India: J of Int Myeloma & Society of Hemotologic Oncology-May 2020
  • Does Interim PET Scan After 2 Cycles Of ABVD Predict Outcome in Hodgkin Lymphoma? RWE: J Global Oncology,Sep2020.
  • Ring Chromosome 8 as a sole abnormality: An adverse prognostic indicator in Acute Myeloid Leukemia?: Atlas Genet Cytogenet Oncol Heamatol.2018;22(1).
  • Dr Satish Kumar on Five incredible facts about chemotherapy I Mirchi Plus Click Here
  • Overview

  • Dr Satish Kumar. A is a clinical Hematologist, Haemato-oncologist and BMT physician and has experience of more than 14 years in the field

  • He is the Hemato-oncologist in Yeshwanthpur Bangalore and Bone Marrow Transplant Physician in Yeshwanthpur Bangalorehas completed DM from prestigious Seth G S Medical college (KEM Hospital) and later pursued Fellowship in Leukemia and Bone Marrow Transplant from Vancouver, Canada
  • He specializes in management of benign and malignant disorders of blood and bone marrow including Stem cell transplantation
  • His expertise includes management of various anaemias, platelet disorders, bleeding and clotting disorders, and blood cancers including Leukaemia, Lymphoma and Myeloma
  • He has expertise to manage blood disorders including cancers in both adults and children

    Talks & Publications

  • A Rare case of familial multiple subcutaneous lipomatosis with novel PALB2 mutation and increased prediction to cancer: Hematol Oncol Stem Cell Ther (2016) 9, 154-156.
  • Heamophagocytic Lymphohistiocytosis (HLH): Case Series in Tertiary Referral Hospital Over Three Years: Journal Of The Association Of Physicians Of India -Nov 2013;Vol.61.
  • Comparison of Diagnostic Yield of FISH Panel Against Conventional Cytogenetic Studies for Hematological Malignancies: A South Indian Referral Laboratory Analysis Of 201 Cases: Asian Pac J Cancer Prev, 18(12), 3457-3464.
  • Halving Time of BCR-ABLI in Chronic Myeloid Leukemia: Is it Better Than Day-90 Value; A Multi-center Study From South India: J of Int Myeloma & Society of Hemotologic Oncology-May 2020
  • Does Interim PET Scan After 2 Cycles Of ABVD Predict Outcome in Hodgkin Lymphoma? RWE: J Global Oncology,Sep2020.
  • Ring Chromosome 8 as a sole abnormality: An adverse prognostic indicator in Acute Myeloid Leukemia?: Atlas Genet Cytogenet Oncol Heamatol.2018;22(1).
  • Dr Satish Kumar on Five incredible facts about chemotherapy I Mirchi Plus Click Here
  • Overview

  • Dr Satish Kumar. A is a clinical Hematologist, Haemato-oncologist and BMT physician and has experience of more than 14 years in the field

  • He is the Hemato-oncologist in Yeshwanthpur Bangalore and Bone Marrow Transplant Physician in Yeshwanthpur Bangalorehas completed DM from prestigious Seth G S Medical college (KEM Hospital) and later pursued Fellowship in Leukemia and Bone Marrow Transplant from Vancouver, Canada
  • He specializes in management of benign and malignant disorders of blood and bone marrow including Stem cell transplantation
  • His expertise includes management of various anaemias, platelet disorders, bleeding and clotting disorders, and blood cancers including Leukaemia, Lymphoma and Myeloma
  • He has expertise to manage blood disorders including cancers in both adults and children

  • Fellowship & Membership

  • Fellowship in Leukemia and BMT.
  • Field of Expertise

  • Clinical Hematology
  • Hemato - Oncology
  • Stem Cell Transplant
  • Languages Spoken

  • English
  • Kannada
  • Hindi
  • Telugu
  • Awards & Achievements

  • Topper in DM Hematology exam at Mumbai university in 2007.
Call Us